Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents

An edition of Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents (2002)

Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents.

By Canadian Coordinating Office for Health Technology Assessment

0 (0 Ratings)

0 Want to read0 Currently reading0 Have read

Publish Date

2003

Publisher

Canadian Coordinating Office for Health Technology Assessment

Language

eng

Pages

Description:

subjects: Chemotherapy, Hypoglycemic agents, Diabetes, Cost-Benefit Analysis, Cost effectiveness, Drug therapy, Diabetes Mellitus, Therapeutic use